This summary was created by AI, based on 2 opinions in the last 12 months.
VitalHub Corp. has shown promising growth in sales and profits, with a strong projection for the next 5 years. The company's margins are healthy and it is expected to grow faster than the industry average. Analysts are bullish on its future performance and believe it could be the next Descartes. The recent financial results look good and the company is well-positioned for future growth.
2Q sales rose 38% to $13.1M; margins dipped to 81% from 83% due to an increase in lower margin service revenue. EBITDA nearly doubled to $1.9M. Net income was $0.72M from a loss last year. Cash was $22M. Results look good to us; Cormark raised its target price slightly. EPS is predicted to double in 2024, with slower growth following the next year.
Unlock Premium - Try 5i Free
Healthcare tech company.
Has owned on and off over the past few years.
Very strong management team.
Multiple is high given current share price.
Defensive software name.
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Sales growth has restarted. Margins contracted slightly. Revenues increased by 36% from the same quarter a year prior. They overall missed their quarter but growth prospects still look pretty good. Unlock Premium - Try 5i Free
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Competition in the space has increased. The valuation has reached above 6x sales. Valuation is more reasonable at 3x sales. The company also has small cap risk but sales growth has been strong. A 5+ years time horizon. Unlock Premium - Try 5i Free
VitalHub Corp. is a Canadian stock, trading under the symbol VHI-T on the Toronto Stock Exchange (VHI-CT). It is usually referred to as TSX:VHI or VHI-T
In the last year, 1 stock analyst published opinions about VHI-T. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for VitalHub Corp..
VitalHub Corp. was recommended as a Top Pick by on . Read the latest stock experts ratings for VitalHub Corp..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered VitalHub Corp. In the last year. It is a trending stock that is worth watching.
On 2024-04-19, VitalHub Corp. (VHI-T) stock closed at a price of $6.03.
Margins are 22% and the company projects 40%. Trades at 18-19x PE. Will grow topline at 15-20% annually for the next 5 years as profits grow faster. Is the next Descartes.
(Analysts’ price target is $6.45)